Brain

Brain Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Tue, 12 Jul 2022 14:45:37 +0000

Summary

Brain Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Brain Hemorrhage pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Brain Hemorrhage, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/univer...

$2,000.00

Brain (Head) Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Tue, 12 Jul 2022 14:45:37 +0000

Summary

Brain (Head) Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Brain (Head) Trauma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Brain (Head) Trauma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, compa...

$2,000.00

Brain Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Tue, 12 Jul 2022 13:47:50 +0000

Summary

Brain Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Brain Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Brain Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university website...

$2,500.00

Brain Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Tue, 12 Jul 2022 13:47:50 +0000

Summary

Brain Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Brain Tumor pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Brain Tumor, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, ...

$2,000.00

Cerebral Infarction (Brain Infarction) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Tue, 12 Jul 2022 13:47:50 +0000

Summary

Cerebral Infarction (Brain Infarction) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Cerebral Infarction (Brain Infarction) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cerebral Infarction (Brain Infarction), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced fr...

$2,000.00

Global Deep Brain Stimulators Market

Fri, 03 Jun 2022 10:32:26 +0000

ResearchCubes Deep Brain Stimulators Market Pulse Report is a great resource to understand the market size, geographical segmentation, products in development, clinical trials, competitive landscape in a fresh new format designed for exploratory research. The report has been conceptualizeed by industry leaders keeping in mind the critical & timely requirement of business information of medical devices business leaders. The report provides a 40,000 feet height and 360 degree view of the medical device segment at an afforable price point. The attempt has been to provide top level data points with the option of access to granualr data if required for an additional cost. • What is the current Deep Brain Stimulators Treatment Devices Market size and future potential? • What is the geographical segmentation of the Deep Brain Stimulators Treatment Devices Market? • What are the emerging pipeline products available in the Deep Brain Stimulators Treatment Devices Market? • What are the various products currently under development/pipeline in the Deep Brain Stimulator...

$2,000.00

Traumatic Brain Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Fri, 08 Apr 2022 11:35:28 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Traumatic Brain Injury (Central Nervous System) pipeline landscape.

Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head or body. Symptoms include headache, dizziness, nausea or vomiting, mood changes, fatigue or drowsiness, difficulty sleeping and memory or concentration problems. Risk factor includes age. Certain types of traumatic brain injury increase the risk of developing Alzheimer's disease and coordination problems.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Traumatic Brain Injury - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on the therapeutics...

$2,500.00

Glioblastoma - Pipeline Insight, 2021

Fri, 19 Mar 2021 14:59:26 +0000

DelveInsight’s, “Glioblastoma – Pipeline Insight, 2021,” report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in Glioblastoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Glioblastoma Understanding Glioblastoma: Overview Glioblastoma, also known as Glioblastoma Multiforme is a fast growing glioma that develops from star shaped glial cells (astrocytes) that supports the health of nerve cells in the brain. A grading system from I to IV defines the rate of tumor growth grade I indicating slow growth and grade IV indicating rapid growth. The exact cause of glioblastoma is unknown. However, there are factors that can influence the risk of glioblastoma. Suspected individuals with glioblastoma undergoes physical and neurological examination. Sophisticated imaging ...

$3,000.00

Cerebral Infarction - Pipeline Insight, 2021

Fri, 19 Mar 2021 14:59:26 +0000

DelveInsight’s, “Cerebral Infarction – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Cerebral Infarction pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Cerebral Infarction Understanding Cerebral Infarction: Overview Infarction refers to death of tissue. A cerebral infarction also known as ischemic stroke, or stroke, is a brain lesion in which a cluster of brain cells die when they don't get enough blood. A lack of adequate blood supply to brain cells deprives them of oxygen and vital nutrients which can cause parts of the brain to die off. The reduced blood supply to the brain is caused by atherosclerosis which gives rise to the formation of a fatty plaque in the blood vessel called an atheroma. Symptoms and signs of a stro...

$2,000.00

Brain Cancer Global Clinical Trials Review, H1, 2020

Mon, 24 Feb 2020 15:56:48 +0000

Summary

GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, H1, 2020" provides an overview of Brain Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advanta...

$2,500.00

Brain Tumor Global Clinical Trials Review, H1, 2020

Mon, 24 Feb 2020 15:56:48 +0000

Summary

GlobalData's clinical trial report, “Brain Tumor Global Clinical Trials Review, H1, 2020" provides an overview of Brain Tumor Clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Tumor. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage....

$2,500.00

Brain Hemorrhage - Market Insights, Epidemiology and Market Forecast-2023

Tue, 25 Apr 2017 20:08:12 +0000

Note*: This report requires 7-10 business days to complete. DelveInsight’s Brain Hemorrhage - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Brain Hemorrhage forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Brain Hemorrhage till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Brain Hemorrhage market. • Identifying patient populations in the global “Brain Hemorrhagemarket to improve product design, pricing, and launch plans. • Organize sales and marketing efforts by identifying the best opportunities for Brain Hemorrhage therapeutics in each of the markets covered. • To u...

$4,950.00

Traumatic Brain Injury- Market Insights, Epidemiology and Market Forecast-2023

Tue, 25 Apr 2017 20:08:12 +0000

Note*: This report requires 7-10 business days to complete. DelveInsight’s Traumatic Brain Injury - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Traumatic Brain Injury forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Traumatic Brain Injury till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Traumatic Brain Injury market. • Identifying patient populations in the global “Traumatic Brain Injury market to improve product design, pricing, and launch plans. • Organize sales and marketing efforts by identifying the best opportunities for Traumatic Brain Injury in each of the...

$4,950.00

Brain Ischemia Global Clinical Trials Review, H2, 2016

Mon, 16 Jan 2017 11:48:58 +0000

Summary

GlobalData's clinical trial report, “Brain Ischemia Global Clinical Trials Review, H2, 2016" provides an overview of Brain Ischemia clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Ischemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive ad...

$2,500.00

Brain Hemorrhage Global Clinical Trials Review, H2, 2016

Mon, 16 Jan 2017 11:48:58 +0000

Summary

GlobalData's clinical trial report, “Brain Hemorrhage Global Clinical Trials Review, H2, 2016" provides an overview of Brain Hemorrhage clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Hemorrhage. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competit...

$2,500.00

Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2016

Fri, 09 Dec 2016 10:18:51 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2016, provides an overview of the Progressive Multifocal Leukoencephalopathy (Infectious Disease) pipeline landscape.

Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the brain caused by lytic infection of oligodendrocytes by the JC polyomavirus. Symptoms include clumsiness, progressive weakness, and visual, speech, and sometimes personality changes. Risk factors include the presence of pathogenic JCV and an altered or weakened immune system, genetic or environmental factors.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Progressive Multifocal Leukoencephalopathy (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of ac...

$2,000.00

Brain Hemorrhage - Pipeline Review, H2 2016

Fri, 09 Dec 2016 10:18:51 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Brain Hemorrhage - Pipeline Review, H2 2016, provides an overview of the Brain Hemorrhage (Central Nervous System) pipeline landscape.

Brain hemorrhage is a type of stroke. It is caused by the bursting of an artery in the brain that leads to localized bleeding in the surrounding tissues. This bleeding kills the brain cells. The common risk factors of brain haemorrhages include head trauma, high blood pressure, aneurysm, blood vessel abnormalities, amyloid angiopathy, blood or bleeding disorders such as hemophilia and sickle cell anemia, liver disease and brain tumors. Symptoms include sudden severe headache, seizures, weakness in an arm or leg, nausea or vomiting, lethargy, changes in vision, tingling or numbness, difficulty in speaking or understanding speech, difficulty in swallowing, difficulty in writing or reading, loss of fine motor skills such as hand tremors, loss of coordination, loss of balance, abnormal sense of taste and loss of consciousness.

R...

$2,000.00

Epiomic Epidemiology Series: Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026

Tue, 18 Oct 2016 09:19:13 +0000

Non-melanoma skin cancer (NMSC) is cancer of the skin not arising from melanocytes. It is one of the most frequently occurring cancers, although it tends not to be reported via registries as prognosis for patients is good in most cases. There are two main types of NMSC malignancies; Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC). BCC is the more predominant type and are a heterogeneous group of tumours ranging from superficial to deeply invasive tumours than can be life threatening. This report provides the current prevalent population for Non-melanoma skin cancer across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity. Providing a value-added level of insight from our analysis team, several of the main symptoms and co-morbidities of Non-melanoma skin cancer have been quantified and presented alongside the ov...

$6,400.00

Epiomic Epidemiology Series: Brain & CNS Cancer Forecast in 19 Major Markets 2016-2026

Thu, 06 Oct 2016 11:26:22 +0000

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Brain & CNS Cancer in 19 Major Markets Primary brain and central nervous system (CNS) tumours (ICD-10 codes C70-C72) are a group of primary tumours arising in the brain, meninges or central nervous system. As such, this is a cluster of conditions rather than one disease per se. There are considered to be over 120 types of brain tumour including glioblastoma multiforme (GBM), meningiomas and astrocytomas. This report provides the current incident population for Brain & CNS Cancer across 19 Major Markets (USA, France, Germany, Italy, Spain, UK, Turkey, Russia, India, Canada, Australia, Japan, China, South Korea, Argentina, Brazil, Mexico, South Africa and Saudi Arabia) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity. Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbid...

$6,400.00

Traumatic Brain Injury - Pipeline Review, H2 2016

Thu, 15 Sep 2016 21:22:00 +0000

Summary

Global Markets Direct’s, ‘Traumatic Brain Injury - Pipeline Review, H2 2016’, provides an overview of the Traumatic Brain Injury pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Traumatic Brain Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Traumatic Brain Injury and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conference...

$2,000.00

Anaplastic Astrocytoma - Pipeline Review, H1 2016

Tue, 07 Jun 2016 19:33:56 +0000

Summary

Global Markets Direct’s, ‘Anaplastic Astrocytoma - Pipeline Review, H1 2016’, provides an overview of the Anaplastic Astrocytoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Anaplastic Astrocytoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Anaplastic Astrocytoma and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conference...

$2,000.00

Cerebral Hypoxia Global Clinical Trials Review, H1, 2016

Tue, 07 Jun 2016 09:32:09 +0000

Summary

GlobalData's clinical trial report, “Cerebral Hypoxia Global Clinical Trials Review, H1, 2016" provides an overview of Cerebral Hypoxia clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebral Hypoxia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competit...

$2,500.00

Brain Ischemia - Pipeline Review, H1 2016

Tue, 31 May 2016 09:45:03 +0000

Summary

Global Markets Direct’s, ‘Brain Ischemia - Pipeline Review, H1 2016’, provides an overview of the Brain Ischemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Brain Ischemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Brain Ischemia and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor present...

$2,000.00

Traumatic Brain Injury - Pipeline Review, H1 2016

Sat, 28 May 2016 19:12:44 +0000

Summary

Global Markets Direct’s, ‘Traumatic brain injury - Pipeline Review, H1 2016’, provides an overview of the Traumatic brain injury pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Traumatic brain injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Traumatic brain injury and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conference...

$2,000.00